Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-01-08

Clinical Trial Update: Haloperidol vs. Valproate in Agitation [Phase 3]

View source ↗

Summary

A Phase 3 randomized trial comparing haloperidol and valproate for psychomotor agitation has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • HALOPERIDOL (HALOPERIDOL LACTATE)
  • Valproate (valproate)

Snippet

Sponsor: Shahid Beheshti University of Medical Sciences | Conditions: Psychomotor Agitation | Phase 3 | Status: COMPLETED